Navigation Links
ULURU Inc. Reports Third Quarter 2010 Financial Results
Date:11/15/2010

61,617130,234528,481435,057COSTS AND EXPENSESCost of goods sold

6,4167,785143,25922,783Research and development

295,781376,191948,9602,006,070Selling, general and administrative

666,205981,2122,405,1235,041,318Amortization of intangible assets

206,454272,102699,252807,551Depreciation

79,07346,424179,053126,002Total Costs and Expenses

1,253,9291,683,7144,375,6478,003,724OPERATING (LOSS)( 1,192,312)( 1,553,480)(3,847,166)(7,568,667)Other Income (Expense)Interest and miscellaneous income

4,8406,6765,55542,296Interest expense

(20,650)(1,926)(37,138)(1,926)Loss on sale of intangible asset

------( 857,839)---Loss on sale of equipment

---------(2,121)(LOSS) BEFORE INCOME TAXES(1,208,122)( 1,548,730)(4,736,588)(7,530,418)Income taxes

------------NET (LOSS)$(1,208,122)$(1,548,730)$ (4,736,588)$ (7,530,418)Basic and diluted net (loss) per common share

$   (0.01)$   (0.02)$  (0.06)$  (0.11)WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

82,084,31666,038,07981,346,13865,723,998ULURU Inc. SELECTED CONDENSED CONSOLIDATED BALANCE SHEET DATASeptember 30, 2010December 31, 2009(Unaudited)(Audited)  Cash and cash equivalents

$
,320,021$
,934,177  Current assets

2,904,0613,544,850  Property and equipment, net

1,452,5041,631,557  Other assets

5,853,4168,203,965  Total assets

10,209,98113,380,372  Current liabilities

1,149,342929,771  Long term liabilities – deferred revenue

1,461,9021,272,843  Total liabilities

2,611,2442,202,614  Total stockholders' equity

7,598,73711,177,758
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Spherix Reports Second Quarter Earnings
11. Tapestry Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Pa. , July 31, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... the closing of its previously announced underwritten public ... at a public offering price of $11.25 per ... offering included 1,000,000 shares issued upon the exercise ...
(Date:7/31/2015)... and SAN DIEGO , ... its parent company Eisai Co., Ltd. (Headquarters: ... , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Helen Torley , "NASDAQ: HALO") have signed a ... name: Halaven ® , "eribulin") in combination with Halozyme,s ...
(Date:7/31/2015)... According to a new market ... Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air ... & Forecast to 2019", published by MarketsandMarkets, the global ... 2014 and is estimated to grow to $1,425.7 Million ... 2014 to 2019. Browse 41 market ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... June 16, 2011 Reportlinker.com announces that a ... catalogue: UK CT Systems – ... http://www.reportlinker.com/p0555197/UK-CT-Systems-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging Short Description ... data on the CT systems in UK. It ...
... Inc., a leading provider of software solutions to ... today announced that a number of pharmaceutical industry ... participate in the creation of a set of ... performance data. Each of the initial sponsors will ...
Cached Medicine Technology:Reportlinker Adds UK CT Systems - Market Trend Till 2016 2DecisionView to Create Clinical Trial Enrollment Benchmarks 2DecisionView to Create Clinical Trial Enrollment Benchmarks 3
(Date:8/1/2015)... , ... August 01, 2015 , ... Tina Wilcoxson, owner ... , Wilcoxson was given that honor by the National Retail Federation, the largest retail ... Wilcoxson was one of three Maine business owners to be named as such. According ...
(Date:8/1/2015)... ... 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair ... first small business donation to kick off the campaign for healing and Well-Being. , ... includes a complete line of raw, organic hair care products, as well as her ...
(Date:7/31/2015)... New York, New York (PRWEB) , ... July 31, 2015 , ... ... started to strut their stuff, Super-Sod debuted their new type of sod called ... with registered trademark application in process. , To commemorate introduction of this new type ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by ... predictive health analytics , Jvion continues to disrupt the predictive analytic and ... that targets patient and population level illness to drive prevention and better health ...
(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation ... Conference Center. The medical community, social workers, law enforcement, and government officials are ... in the effort to better understand and combat sex trafficking. Lead by sex ...
Breaking Medicine News(10 mins):Health News:Local Retail Advocate Wins National Recognition 2Health News:March4thforWellBeing Foundation Kickoff 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3
... with HIV/AIDS have opposed a patent application filed by ... combination AIDS drug on the grounds that it would ... by the Lawyers' Collective HIV/AIDS Unit, the Indian Network ... of Positive People Thursday officially submitted their opposition to ...
... from Duke University Medical Center and John Hopkins University ... signaling pathway that plays a vital role in the ... injury lead to the development of liver cancer. ... in immature, stem-like liver cells. This discovery could lead ...
... to propagate a new method of sex education for youngsters ... with the China Family Planning Association, said: 'Puberty and child-bearing ... is lagging behind.' ,China now has more than ... million become sexually mature each year. ,Education ...
... an alarming rise in obesity among city kids in Britain, increasing ... 37% of the urban kids really walk to school as compared ... of the kids spend almost 4 hrs sedentarily, watching television or ... of Type 2 diabetes, which was common only in the above ...
... using tissue cultures suggests, that a pain killing medication helps ... to a common form of breast cancer. The name of ... labs experiments on breast cancer cells, scientists found that derivatives ... in estrogen-dependent breast cancer. This form of cancer is the ...
... Hopkins joined the aid efforts by identifying more than ... // The devastating natural disaster, which hit Louisiana and ... Even though most of victims were identified by their ... analysis. ,Using experience gained in DNA analysis of ...
Cached Medicine News:Health News:HIV Patients Opposes Patenting Of AIDS Drug 2Health News:Unchecked Cellular Repair Pathway Causes Liver Cancer 2Health News:Pain-killer Drug Can Help Fight Breast Cancer 2Health News:Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims 2Health News:Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: